Literature DB >> 9291442

Microsatellite instability in sporadic-colon-cancer patients with and without liver metastases.

W S Chen1, J Y Chen, J M Liu, W C Lin, K L King, J Whang-Peng, W K Yang.   

Abstract

Microsatellite instability (MSI) is intrinsic to most colorectal carcinomas (CRC) from patients with hereditary nonpolyposis colorectal cancer (HNPCC), reflecting germline mutations in the mismatch-repair (MMR) genes. Its occurrence and chronological sequence of development in sporadic CRC appears less well defined. To explore the time sequence in acquisition of MSI, and the role it plays during tumor progression in sporadic CRC, we compared the incidence of MSI in tissue samples from 40 Dukes'-B and 30 Dukes'-D CRC patients with liver metastases, at 4 different microsatellite loci, representing sites on the APC, DCC and p53 genes respectively as well as the D2S123 site. Among the 30 patients with hepatic metastases, MSI was found in 9 (30%) of the primary, and 13 (43.3%) of the metastatic tumors. In comparison, among the 40 Dukes'-B CRC, MSI was found in only 8 cases (20%). CRC with MSI were more frequently located in the right colon, less frequently on the left side, and seldom in the rectum. Tumor ploidy analysis shows that 46.2% of Dukes'-D primary tumors with MSI are diploid (chi2 = 4.46, p = 0.035). With a mean follow-up time of 4.2 years for the Dukes'-B CRC, there were no recurrences in the 8 patients with MSI, whilst 6 (18.8%) relapses occurred amongst the 32 patients without MSI, average time to recurrence being 15 months. In Dukes'-D CRC, mean survival time for patients with MSI was 37 months (95% CI, 24 to 51 months), for those without MSI 26 months (95% CI, 18 to 35 months), although this was not statistically significant. Our data suggest that tumor progression may involve increased genetic instability.

Entities:  

Mesh:

Year:  1997        PMID: 9291442     DOI: 10.1002/(sici)1097-0215(19970822)74:4<470::aid-ijc20>3.0.co;2-c

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  10 in total

1.  Loss of hMSH2 gene expression correlates with improved survival in patients with sporadic colorectal cancer.

Authors:  Ewa Langner; Karolina Przybylowska; Radzislaw Trzcinski; Michal Mik; Przemyslaw Galbfach; Beata Smolarz; Hanna Romanowicz-Makowska; Janusz Smigileski; Andrzej Kulig; Adam Dziki
Journal:  J Genet       Date:  2010-04       Impact factor: 1.166

2.  Impact of BRAF mutation and microsatellite instability on the pattern of metastatic spread and prognosis in metastatic colorectal cancer.

Authors:  Ben Tran; Scott Kopetz; Jeanne Tie; Peter Gibbs; Zhi-Qin Jiang; Christopher H Lieu; Atin Agarwal; Dipen M Maru; Oliver Sieber; Jayesh Desai
Journal:  Cancer       Date:  2011-03-31       Impact factor: 6.860

Review 3.  Microsatellite instability in metastatic colorectal cancer: a review of pathology, response to chemotherapy and clinical outcome.

Authors:  Kein-Leong Yim
Journal:  Med Oncol       Date:  2011-09-08       Impact factor: 3.064

Review 4.  [Current status of the prognostic value of molecular markers in patients with colorectal cancer and the prediction of response to adjuvant therapy].

Authors:  Jose M Fernández-Cebrián; Peter Vorwald Kuborn; Mar Pardo de Lama; Alfonso Sanjuanbenito Dehesa; Manuel Nevado Santos; Pedro A Pacheco Martínez; Beatriz Fernández-Escudero
Journal:  Clin Transl Oncol       Date:  2005-04       Impact factor: 3.405

5.  Six mutator-derived lncRNA signature of genome instability for predicting the clinical outcome of colon cancer.

Authors:  Shujia Chen; Xiaofei Li; Jiachen Zhang; Li Li; Xueqiu Wang; Yinghui Zhu; Lianyi Guo; Jiwei Wang
Journal:  J Gastrointest Oncol       Date:  2021-10

6.  Value of the identification of microsatellite instability in colorectal cancer.

Authors:  Antonio Barrasa Shaw; José Antonio López-Guerrero; Ana Calatrava Fons; Zaida García-Casado; Vicente Alapont Olavarrieta; Jorge Campos Máñez; Carlos Vázquez Albaladejo
Journal:  Clin Transl Oncol       Date:  2009-07       Impact factor: 3.405

7.  Predictive and prognostic value of microsatellite instability in patients with advanced colorectal cancer treated with a fluoropyrimidine and oxaliplatin containing first-line chemotherapy. A report of the AIO Colorectal Study Group.

Authors:  C I Müller; K Schulmann; A Reinacher-Schick; N Andre; D Arnold; A Tannapfel; H Arkenau; S A Hahn; S H-J Schmoll; R Porschen; W Schmiegel; U Graeven
Journal:  Int J Colorectal Dis       Date:  2008-07-02       Impact factor: 2.571

Review 8.  Colorectal Liver Metastases: Does the Future of Precision Medicine Lie in Genetic Testing?

Authors:  Carlotta Barbon; Georgios Antonios Margonis; Nikolaos Andreatos; Neda Rezaee; Kazunari Sasaki; Stefan Buettner; Christos Damaskos; Timothy M Pawlik; Jin He; Christopher L Wolfgang; Matthew J Weiss
Journal:  J Gastrointest Surg       Date:  2018-04-11       Impact factor: 3.452

Review 9.  Cell cycle control, checkpoint mechanisms, and genotoxic stress.

Authors:  R E Shackelford; W K Kaufmann; R S Paules
Journal:  Environ Health Perspect       Date:  1999-02       Impact factor: 9.031

Review 10.  Genetics of colorectal cancer.

Authors:  I Munteanu; B Mastalier
Journal:  J Med Life       Date:  2014 Oct-Dec
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.